![Han-Gu Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 4 M $ as of 29/06/2026
Han-Gu Lee worked as the Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd., HLB Pharmaceutical Co., Ltd., and RedoxBio Co., Ltd. He started his job at HLB Pharmaceutical Co., Ltd. in 2016 and ended it in 2017.
Dr. Lee received his undergraduate and doctorate degrees from Sungkyunkwan University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/12/2025 | 596,327 ( 3.2% ) | 4 M $ | 29/06/2026 |
| Companies | Position | End |
|---|---|---|
RedoxBio Co., Ltd.
 RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Chief Executive Officer | 30/05/2024 |
| HLB PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 30/05/2017 |
| DAE HWA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 19/03/2015 |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
DAE HWA PHARM Co., Ltd.
 DAE HWA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sungkyunkwan University
 Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HLB Pharmaceutical Co., Ltd.
 HLB Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and related products based on biotechnology | Health Technology |
RedoxBio Co., Ltd.
RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
